###begin article-title 0
###xml 84 88 <span type="species:ncbi:10090">Mice</span>
Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice
###end article-title 0
###begin p 1
###xml 36 55 36 55 <email xmlns:xlink="http://www.w3.org/1999/xlink">nm2170@columbia.edu</email>
Corresponding author: Nino Mzhavia, nm2170@columbia.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-Identification of arterial genes and pathways altered in obesity and diabetes.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
RESEARCH DESIGN AND METHODS-Aortic gene expression profiles of obese and diabetic db/db, high-fat diet-fed C57BL/6J, and control mice were obtained using mouse Affymetrix arrays. Neuronatin (Nnat) was selected for further analysis. To determine the function of Nnat, a recombinant adenovirus (Ad-Nnat) was used to overexpress the Nnat gene in primary endothelial cells and in the mouse aorta in vivo.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 850 851 834 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
RESULTS-Nnat, a gene of unknown vascular function, was upregulated in the aortas of db/db and high-fat diet-fed mice. Nnat gene expression was increased in db/db mouse aorta endothelial cells. Nnat protein was localized to aortic endothelium and was selectively increased in the endothelium of db/db mice. Infection of primary human aortic endothelial cells (HAECs) with Ad-Nnat increased expression of a panel of nuclear factor-kappaB (NF-kappaB)-regulated genes, including inflammatory cytokines, chemokines, and cell adhesion molecules. Infection of mouse carotid arteries in vivo with the Ad-Nnat increased expression of vascular cell adhesion molecule 1 protein. Nnat activation of NF-kappaB and inflammatory gene expression in HAECs was mediated through pathways distinct from tumor necrosis factor-alpha. Nnat expression stimulated p38, Jun NH2-terminal kinase, extracellular signal-related kinase, and AKT kinase phosphorylation. Phosphatidylinositol 3-kinase and p38 inhibitors prevented Nnat-mediated activation of NF-kappaB-induced gene expression.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
CONCLUSIONS-Nnat expression is increased in endothelial cells of obese and diabetic mouse blood vessels. The effects of Nnat on inflammatory pathways in vitro and in vivo suggest a pathophysiological role of this new gene in diabetic vascular diseases.
###end p 6
###begin p 7
Published ahead of print at  on 30 June 2008.
###end p 7
###begin p 8
H.M.D. is currently Director of Clinical Research, Cardiovascular Disease, Merck Research Laboratories, Rahway, New Jersey.
###end p 8
###begin p 9
These studies were begun under the supervision of H.M.D. and completed with supervision from I.G.
###end p 9
###begin p 10
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 10
###begin p 11
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 623 624 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 675 676 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 677 678 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
Epidemiological data has shown a strong association between diabetes and coronary heart disease (1,2). Although insulin-mediated improved glucose control reduced cardiovascular events in subjects with type 1 diabetes (3), less definitive information is available relating diabetes control and atherosclerosis prevention in type 2 diabetes. Recent findings suggest that hyperglycemia is associated with increased arterial wall inflammation (4) and increased expression of vascular inflammatory molecules, such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-Selectin (SELE) (5,6); nuclear factor-kappaB (NF-kappaB) activation (7,8); and inflammatory cytokine production. Fundamental understanding of the effects of diabetes on arterial genes and pathways may contribute to the discovery of new strategies for the treatment of diabetic vascular diseases beyond blood glucose control.
###end p 11
###begin p 12
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 206 211 <span type="species:ncbi:10090">mouse</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 454 459 <span type="species:ncbi:10090">mouse</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 715 720 <span type="species:ncbi:10090">mouse</span>
Animal models of diabetes have been used to study the effects of hyperglycemia and insulin resistance at different stages of disease progression (9,10). We (11,12) and others (13,14) have demonstrated that mouse models of type 2 diabetes such as leptin receptor mutant db/db and diet-induced obesity mice have impaired vascular function. Kim et al. (15) demonstrated that high-fat diet feeding increases expression of markers of vascular inflammation in mouse thoracic aortas. Also, apolipoprotein E knockout db/db mice have increased VCAM-1 expression in aorta (16) and greater aortic sinus atherosclerosis (16,17). However, not all investigators have observed changes in expression of adhesion molecules in db/db mouse aortas (18).
###end p 12
###begin p 13
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 646 648 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 649 651 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
A number of studies have focused on the effects of diabetes on vascular cells. Endothelial cells isolated from db/db aortas have increased inflammatory cytokine and chemokine expression and more monocyte adhesion (19-21). The reasons for the altered biology of these cells is thought by many to be due to hyperglycemia; increased glucose concentrations induce interleukin (IL)-6, IL-8, and monocyte chemotactic protein-1 (MCP-1) secretion and adhesion molecule expression in endothelial cells. IL-6/IL-6Ralpha complex can induce an inflammatory phenotype in endothelial cells, promoting SELE, ICAM-1, and VCAM-1 expression and monocyte adhesion (21,22).
###end p 13
###begin p 14
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 515 520 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:10090">mouse</span>
In the current study, we performed gene expression profiling of aortas from two mouse models of type 2 diabetes to identify new genes and pathways that contribute to diabetic vascular diseases. We found that neuronatin (Nnat), a gene with unknown vascular function, was upregulated in the aortas of both db/db and high-fat diet-fed mice. Immunohistochemical studies localized Nnat to the vascular endothelium. To gain insight into the function of this molecule, the effects of adenovirus-induced Nnat expression in human aortic endothelial cells (HAECs) and mouse arteries were studied.
###end p 14
###begin title 15
RESEARCH DESIGN AND METHODS
###end title 15
###begin p 16
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 123 128 123 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">db/db</sup>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>db/db</sup></italic>
###xml 174 176 174 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">Mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
All procedures were approved by the institutional animal care and use committee. Male C57BL/6J (strain 000664), db/db (Leprdb/db strain 000642), and heterozygous littermate (db/+) mice were purchased from The Jackson Laboratories (Bar Harbor, ME). Mice were maintained in a temperature-controlled barrier facility with a 12-h light/dark cycle and were given free access to food and water. db/db mice were killed at 16-20 weeks of age. To induce obesity and diabetes, C57BL/6J mice were fed a high-fat TD03584 diet (Harlan Tekland, Indianapolis, IN) for 16-20 weeks starting at the age of 10 weeks. Control mice were fed regular chow. The high-fat diet contained 35% fat and 37% carbohydrate.
###end p 16
###begin title 17
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse aorta endothelial cell isolation.
###end title 17
###begin p 18
###xml 450 451 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1030 1031 1017 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
Endothelial cells were isolated by sorting with magnetic beads using anti-platelet-endothelial cell adhesion molecule-1 (CD31) biotin-conjugated antibody (Millipore). In brief, mice were anesthetized and perfused with 1,000 units/ml heparin in PBS. Aortas were isolated, stripped of perivascular fat, and incubated in RPMI containing 2 mg/ml collagenase 2 and 2 units/ml dispase for 30 min at 37degreesC. Cells were collected by centrifugation at 400g at 4degreesC and washed twice with MACS (magnetic cell sorting) buffer (Hanks' balanced salt solution [Ca/Mg free], 2 mmol/l EDTA, and 0.5% BSA). The cells suspension was run through 70- and 40-mum cell strainers. Cells were incubated with CD31 antibody for 15 min, washed and incubated with streptavidin SA-Microbeads (Miltenyi Biotec) for another 15 min, washed again, and applied to an equilibrated column. After several washes, the column was removed from the magnetic holder, and cells were eluted with MACS buffer. Endothelial cells were collected by centrifugation at 400g and processed for RNA isolation.
###end p 18
###begin title 19
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
Expression of adenovirus-encoded Nnat in endothelial cells.
###end title 19
###begin p 20
HAECs were obtained from Cambrex Life Science. Cells were grown in endothelial cell growth medium EGM-2 to confluency and were infected with Ad-Nnat, Ad-green fluorescent protein (Ad-GFP), or Ad-Empty at multiplicity of infection (MOI) 10 unless indicated otherwise. Gene expression was assessed by real-time PCR, and proteins were analyzed by Western blot 48 h after infection. For treatment with tumor necrosis factor-alpha (TNF-alpha), TNF-alpha-blocking antibody, or kinase inhibitors, cells were treated 24 h after infection for another 24 h. Kinase inhibitors used in the study are 20 mumol/l U0126, 20 mumol/l SP600125, 5 mumol/l IKK-VII, 10 mumol/l SB202190, 50 mumol/l LY294002, and 0.2 mumol/l wortmannin.
###end p 20
###begin title 21
Real-time PCR.
###end title 21
###begin p 22
###xml 325 326 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 475 476 471 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 442 447 <span type="species:ncbi:9606">human</span>
Primers for conventional real-time PCR were designed (supplementary Table S1, available in an online appendix at ) or obtained from SuperArray Bioscience (Frederick, MD). Expression levels for individual genes were normalized to beta-actin in mouse tissue and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in HAECs. For RT2 Profiler PCR array, 1 mug RNA pool from HAECs infected with adenovirus was used for cDNA synthesis and analysis by human endothelial cell biology RT2 Profiler PCR array according to manufacturer's instructions (SuperArray Bioscience).
###end p 22
###begin title 23
Western blot analysis.
###end title 23
###begin p 24
###xml 473 474 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Cell homogenates were made in buffer (10 mmol/l Tris-Cl, pH 7.4; 5 mmol/l EDTA; 150 mmol/l NaCl; 10% glycerol; and 1% Triton X-100) containing a protease inhibitor cocktail for mammalian tissues (Sigma-Aldrich, St. Louis, MO) and phosphatase inhibitors (Roche Applied Science, Indianapolis, IN). Antibodies used are as follows: inhibitor of kappaB (IkappaB)-alpha, ICAM-1, and VCAM-1 (Santa Cruz Biotechnology, Santa Cruz, CA); stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK), p38, extracellular signal-related kinase 1/2 (ERK1/2), NF-kappaB activating kinase (NAK), p65, and Akt (Cell Signaling Technology); SELE (BioVision); beta-actin (ABcam); and TNF-alpha (BioLegend).
###end p 24
###begin title 25
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
Gene transfer into mouse carotid artery.
###end title 25
###begin p 26
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
According to the method of Vassalli et al. (23), in vivo gene transfer was conducted using Ad-GFP or Ad-Nnat virus. Two days after the adenovirus infection, carotid arteries were isolated and fixed in 4% paraformaldehyde and processed for immunohistochemical analysis as described above. Intensity of staining was determined in sections from 4 to 7 Ad-Nnat-and Ad-GFP-infected mouse carotid arteries using Image Pro Plus software.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Gene expression profiling of aortas from diabetic mice.
###end title 28
###begin p 29
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 381 386 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 604 609 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 615 617 603 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 725 730 713 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 767 769 755 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 1077 1084 1065 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 1178 1182 1166 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 1330 1334 1318 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 1376 1381 1364 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 1511 1515 1499 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
###xml 1541 1545 <span type="species:ncbi:10090">mice</span>
Gene expression profiling was performed to identify differentially expressed genes in the aortas of diabetic mice. Metabolic data for db/db and high-fat diet-fed C67BL6/J mice are shown in Table 1. To create mice with comparable weights and insulin levels, we used 16- to 18-week-old db/db mice and approximately28-week-old high-fat diet-fed animals. Glucose levels were higher in db/db compared with high-fat diet-fed mice, but body weight (47 and 49 g, respectively) and insulin (912 and 775 pmol/l, respectively) were comparable between the two groups. As expected, cholesterol levels were greater in db/db than db/+ mice. Expression of 43 genes increased and expression of 3 genes decreased at least twofold in aortas of db/db mice when compared with nondiabetic db/+ controls (supplementary Table S2). In high-fat diet-fed mice, 85 aortic genes were upregulated, and 42 aortic genes were downregulated (supplementary Table S3). Analysis of gene expression across the two diabetic models revealed 10 genes that were differentially expressed in the aortas of diabetic mice (Table 2), but there were only 4 genes in which the direction of change was similar. These genes were Nnat, leptin, natriuretic peptide receptor 3, and lectin galactose binding, soluble 3. Among these common genes, the most strongly upregulated gene was Nnat. Nnat mRNA was upregulated 9-fold in the db/db and 2.5-fold in the high-fat diet-induced model. Therefore, we elected to focus our subsequent studies on identifying a role for Nnat in the aorta of diabetic mice.
###end p 29
###begin title 30
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Nnat was upregulated in the aortic endothelium of diabetic mice.
###end title 30
###begin p 31
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 212 213 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 206 213 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 315 316 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 404 417 404 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic> and <italic>C</italic></xref>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 616 617 616 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 604 617 604 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic> and <italic>C</italic></xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
Real-time PCR was performed to quantify Nnat expression in the mouse aorta. Nnat mRNA expression was higher in the aorta of db/db and high-fat diet-fed diabetic mice when compared with littermate controls (Fig. 1A). Immunohistochemical staining of mouse aorta localized the Nnat protein in endothelial cells (Fig. 1B). Compared with control mice, the endothelium of db/db mice had more intense staining (Fig. 1B and C). The difference in Nnat staining was less prominent in the aortas from high-fat diet-fed compared with chow diet-fed control mice, and the difference was not statistically significant (Fig. 1B and C). Analysis of aorta sections stained with Nnat antibody revealed that not only endothelial cells but also perivascular fat stains positive for Nnat (supplementary Fig. S2).
###end p 31
###begin title 32
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Nnat gene expression was increased in endothelial cells of db/db mouse aorta.
###end title 32
###begin p 33
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 341 346 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F4/80</italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Col3a</italic>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 484 494 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;-Nnat</italic>
###xml 550 555 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 593 594 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 587 594 583 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 675 676 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 669 676 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>E</italic></xref>
###xml 807 808 796 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 801 808 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>F</italic></xref>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
To reassure that the increase in Nnat is due to endothelial cell expression, we isolated mouse aorta endothelial cells using magnetic bead cell sorting with CD31 antibody. Endothelial cell isolation was confirmed by assessing endothelial-specific (endothelial nitric oxide [NO] synthase, vascular endothelial-cadherin), macrophage-specific (F4/80), and fibroblast- and smooth muscle cell-specific (Col3a) gene expression in CD31-positive and -negative cells (supplementary Fig. S2A). alpha-Nnat expression was increased approximately fourfold in the db/db endothelial cell preparations (Fig. 1D), whereas total nnat expression was increased only approximately twofold (Fig. 1E); the confirmation that this analysis detected both alpha- and beta-isoforms of Nnat in mouse endothelial cells is shown in Fig. 1F. Because total Nnat expression changed less than alpha-Nnat, it is likely that beta-Nnat expression did not change or decreased in these mice.
###end p 33
###begin title 34
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
Nnat expression in cultured primary aortic endothelial cells.
###end title 34
###begin p 35
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 445 449 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 492 496 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 540 544 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 735 736 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 914 915 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
The effects of Nnat expression were investigated in cultured HAECs. At baseline conditions, real-time PCR and Western blotting studies revealed low levels of transcript and no detectable protein in these cells (data not shown). To determine whether metabolic stimuli would induce Nnat expression, HAECs were cultured for 1-4 days in the presence of 25 mmol/l glucose, 100 ng/ml leptin, or 10 mug/ml insulin. These manipulations did not increase Nnat gene expression (data not shown). Because Nnat is an imprinted gene, it was possible that Nnat expression was repressed by DNA methylation. Treatment of HAECs with 5-Aza-2'-deoxycytidine (ADC), an inhibitor of DNA methyl transferase, increased Nnat mRNA levels (supplementary Figure S4A). Treatment of the cells with high-glucose insulin and leptin after induction of Nnat expression with ADC did not result in the further increase of Nnat (supplementary Figure S4B).
###end p 35
###begin p 36
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 169 182 169 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic> and <italic>C</italic></xref>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 668 669 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 760 761 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 810 811 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 933 934 926 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 1241 1248 1227 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
HAECs were infected with an Ad-Nnat to determine the downstream effects of Nnat expression. Western blotting revealed high levels of the Nnat protein in infected cells (Fig. 2A and C; see below). Because the function of Nnat in endothelium was unknown, we compared gene expression in endothelial cells infected with Ad-Nnat to that of an empty adenovirus control (Ad-Empty) using an endothelial cell biology RT2 Profiler PCR array. Of 84 endothelial-specific genes, 27 were differentially regulated in Ad-Nnat-infected cells. Twenty-one genes were increased, and six were decreased (supplementary Table S4). Among the increased genes, four major groups were apparent: 1) cytokines (IL-1beta, IL-6, IL-7, IL-11, and TNF-alpha) and chemokines (CX3CL1 and CCL2); 2) adhesion molecules (ICAM-1, VCAM-1, and SELE); 3) growth factors (vascular endothelial growth factor, endothelial cell growth factor-1, and placental growth factor); and 4) extracellular matrix proteases/inhibitors (matrix metallopeptidase-1; serpin peptidase inhibitor, clade E, member-1; and plasminogen activator urokinase). The changes in TNF-alpha, IL-1beta, IL-6, MCP-1 (CCL2), ICAM-1, VCAM-1, and SELE expression in Ad-Nnat-infected cells were verified by real-time PCR (Table 3). These results suggest that Nnat expression activates endothelial cells.
###end p 36
###begin title 37
Nnat expression activates NF-kappaB in endothelial cells.
###end title 37
###begin p 38
###xml 301 302 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 295 302 283 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 334 335 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 328 335 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 613 614 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 607 614 583 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 729 730 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 723 730 695 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
Many genes induced by Nnat expression in HAECs are regulated by NF-kappaB. To study this, HAECs were infected with increasing numbers of Ad-Nnat particles per cell from MOI 3 to 20. At MOI 10-20, Nnat protein expression paralleled with IkappaB-alpha decrease and with ICAM-1 and VCAM-1 protein (Fig. 2A) and IL-6 mRNA increase (Fig. 2B). Time course analysis of Nnat expression also demonstrated that accumulation of Nnat protein was accompanied by an increase of immunoreactive NAK, a decrease in IkappaB-alpha, and an increase in phosphorylation of the p65 subunit of the NF-kappaB transcription complex (Fig. 2C). Increases in IL-6 accompanied the time-dependent increase in Nnat expression and activation of NF-kappaB (Fig. 2D). ICAM-1 and TNF-alpha mRNA expression also increased with time, and IL-1beta and SELE were increased only after 48 h (data not shown).
###end p 38
###begin title 39
Nnat- versus TNF-alpha-induced activation of NF-kappaB transcription factor.
###end title 39
###begin p 40
###xml 187 194 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 644 645 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 638 645 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
Additional experiments were performed to identify the signal transduction pathways by which Nnat activated NF-kappaB in endothelial cells. Because Nnat induced TNF-alpha mRNA expression (Table 3), we entertained the possibility that Nnat might induce inflammatory gene expression through stimulation of TNF-alpha release by the cell, leading to ligation of TNF-alpha cell surface receptors. Cells were first infected with Ad-Nnat to determine whether Nnat expression would result in activation of NF-kappaB in the presence of exogenous TNF-alpha. Treatment of Ad-Empty-infected HAECs with TNF-alpha decreased IkappaB-alpha protein level (Fig. 3A). Treatment of Nnat-expressing HAECs with TNF-alpha further decreased IkappaB-alpha protein.
###end p 40
###begin p 41
###xml 148 149 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 142 149 130 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 236 237 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 242 243 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 230 243 218 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic> and <italic>C</italic></xref>
###xml 379 381 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
We then removed any cellular TNF-alpha using a neutralizing antibody. This did not block the Nnat-mediated decrease in IkappaB-alpha protein (Fig. 3B), increase in ICAM-1 mRNA, or increase in ICAM-1 and VCAM-1 protein expression (Fig. 3B and C). Expression of VCAM-1 was increased with antibody treatment; VCAM-1 shedding was decreased by TNF-alpha absence in the culture media (24).
###end p 41
###begin p 42
###xml 158 159 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 152 159 144 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 236 240 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-6</italic>
###xml 291 295 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL-6</italic>
IL-6 mRNA expression, another read-out for NF-kappaB activation, was increased by TNF-alpha, and this was further augmented by Ad-Nnat viral infection (Fig. 3D). TNF-alpha neutralizing antibody blocked the TNF-alpha induced increase in IL-6 gene expression but had no effect on Nnat induced IL-6 gene expression. These data indicate that Nnat activates the NF-kappaB transcription factor and induces inflammatory gene expression by a pathway that does not require cell surface TNF-alpha receptor activation.
###end p 42
###begin title 43
Nnat expression in HAEC-activated kinases.
###end title 43
###begin p 44
###xml 390 391 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 384 391 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>E</italic></xref>
###xml 582 583 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 576 583 560 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>F</italic></xref>
As we have shown above, Nnat expression increased NAK and phospho-p65 and decreased IkappaB-alpha protein. To learn what kinases were involved in the signal transduction from Nnat to NAK or p65 phosphorylation, we looked at mitogen-activated protein kinase (MAPK) activation and compared it with that of TNF-alpha. Nnat expression induced phosphorylation of p38, JNK, and ERK kinase (Fig. 3E). TNF-alpha treatment of HAECs induced phosphorylation of p38 and JNK kinase but decreased Nnat-induced ERK phosphorylation. Nnat expression in HAECs also induced Akt phosphorylation (Fig. 3F), suggesting a role in activation of phosphatidylinositol 3-kinase (PI 3-kinase).
###end p 44
###begin title 45
Nnat induced signal transduction in endothelial cells.
###end title 45
###begin p 46
###xml 289 295 281 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 855 856 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 861 862 825 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 849 862 813 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>B</italic> and <italic>C</italic></xref>
###xml 1106 1107 1058 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1116 1117 1068 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1826 1827 1770 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1820 1827 1764 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4<italic>D</italic></xref>
To test whether Nnat-induced kinase phosphorylation was involved in activation of NF-kappaB, we treated Ad-Nnat-infected endothelial cells with p38 (SB202190), JNK1,2,3 (SP600125), ERK1/2 kinase (U0126), PI 3-kinase (LY294002 and wortmannin), or IkappaB kinase (IKK) (IKK-VII) inhibitors (Fig. 4). SB202190, LY294002, wortmannin, and IKKVII blocked the Nnat-induced IkappaB-alpha degradation and increase in VCAM-1 protein. U0126 had the opposite effect; it further increased VCAM-1 expression. SP600125 deceased VCAM-1 protein expression without affecting IkappaB-alpha protein levels. LY294002 and wortmannin partially decreased phosphorylation of p65 subunit. SB202190, SP600125, and IKK-VII had no effect. Both LY294002 and SB202190 blocked (approximately95%) the increase in IL-6 and SELE gene expression in Ad-Nnat-infected endothelial cells (Fig. 4B and C). U0126 had the opposite effect and increased IL-6 and SELE expression. SP600125 inhibitor only partially (approximately40%) blocked the Nnat-mediated increase in IL-6 but not SELE expression. U0126 inhibited ERK phosphorylation and increased p-JNK and p-AKT. SB202190 decreased AKT and increased ERK phosphorylation. SP600125 decreased JNK and p38 phosphorylation without having an effect on others. This inhibitor is able to inhibit kinases upstream of p38 and JNK. We could speculate that partial inhibition of IL-6 but not SELE expression by this compound is a result of blocking kinase upstream from p38 but not JNK itself. LY294002 and wortmannin blocked Nnat-induced phosphorylation of NAK, p38, and JNK, suggesting that these kinases are downstream from PI 3-kinase. IKK-VII treatment blocked IkappaB-alpha degradation and did not effect p65 phosphorylation. On the other hand, IKK-VII inhibited phosphorylation of all three MAPKs. As summarized in Fig. 4D, Nnat effects on NF-kappaB appear to be mediated via PI 3-kinase and p38 and inhibited by ERK1/2.
###end p 46
###begin title 47
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Adenovirus-induced expression of Nnat in mouse carotid arteries.
###end title 47
###begin p 48
###xml 531 537 531 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 166 171 <span type="species:ncbi:10090">Mouse</span>
To test whether Nnat can induce adhesion molecule expression in endothelium in vivo, Ad-Nnat or Ad-GFP was injected into carotid arteries of C57BL/6J wild-type mice. Mouse arteries were harvested 2 days after infection, and arterial sections were processed for determination of immunoreactive Nnat and VCAM-1. Ad-Nnat increased the intensity of staining for the Nnat protein in the endothelium approximately fourfold. Staining for VCAM-1 increased by ninefold compared with staining of arteries that had been infected with Ad-GFP (Fig. 5). These data demonstrate that expression of Nnat in endothelium induces endothelial expression of adhesion molecules in vivo.
###end p 48
###begin title 49
DISCUSSION
###end title 49
###begin p 50
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 319 324 319 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 648 653 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 949 951 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 1387 1389 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 1547 1549 1547 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 257 262 <span type="species:ncbi:10090">mouse</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 363 368 <span type="species:ncbi:10090">mouse</span>
###xml 1518 1524 <span type="species:ncbi:9606">humans</span>
In the present study, using Affymetrix arrays, we found that Nnat, a gene with unknown vascular functions, was upregulated in both db/db and high-fat diet-fed mouse aortas. Diabetes-associated changes in gene expression were quite different between the two mouse models. Although insulin resistance was present in both db/db and high-fat diet-fed mice, the db/db mouse has higher glucose levels. The degree of metabolic abnormalities, the duration of diabetes (longer in db/db), and the effect of the high-fat diet may be responsible for the differences in gene expression across the two diabetic models. Some gene expression changes found only in db/db aortas are known to be associated with obesity or diabetes. Angiopoietin-like protein 4 (ANGPTL4), which is increased in the db/db aorta, inhibits lipoprotein lipase activity in vitro (25). ANGPTL4 also markedly inhibits the proliferation, chemotaxis, and tubule formation of endothelial cells (26). Two genes, other than leptin and Nnat, were increased in both models of obesity and insulin resistance: lectin, galactose binding, soluble 3, galectin-3 (LGALS3) and natriuretic peptide receptor 3 (Npr3). LGALS3 produces a receptor that interacts with advanced glycation end products (27). Npr3 encodes for a receptor for natriuretic peptides, which are important in the maintenance of blood pressure and extracellular fluid volume (28). Another gene differentially expressed in this model is transthyretin. Blood levels of transthyretin are increased in serum of humans with type 2 diabetes (29).
###end p 50
###begin p 51
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 389 391 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 394 398 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 634 636 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 199 202 <span type="species:ncbi:10116">rat</span>
###xml 275 280 <span type="species:ncbi:10090">mouse</span>
###xml 319 324 <span type="species:ncbi:10090">mouse</span>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 355 360 <span type="species:ncbi:10090">mouse</span>
Immunohistochemical staining revealed that Nnat was expressed on the vascular endothelium. The function of Nnat in vascular tissue is unknown. Previous studies identified Nnat mRNA in the developing rat brain (30). Nnat is an imprinted gene (31) and is expressed in neonatal mouse brain, eye, bladder, colon, and lung; mouse and human pituitary (32); and mouse pancreatic beta-cell lines (33). Nnat expression in pancreas appears to be regulated by the beta2 transcription factor, also known as NeuroD1. Knockdown of Nnat with small interfering RNA in the pancreatic beta-cell line NIT1 deceased glucose-stimulated insulin secretion (34).
###end p 51
###begin p 52
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 728 729 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 845 850 845 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 886 893 886 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 1014 1018 1014 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 1333 1335 1333 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 344 349 <span type="species:ncbi:9606">human</span>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 555 563 <span type="species:ncbi:9606">Patients</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
It is not clear why Nnat expression was increased in endothelial cells of obese and diabetic mice. Nnat is an imprinted gene because its expression should be increased by hypomethylation. Recent studies by several groups found changes in concentrations of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) associated with diabetes in human subjects and in animal models (35,36). SAM is a universal donor of methyl groups. Increased intracellular SAH levels are associated with DNA hypomethylation in human umbilical vein endothelial cells (37). Patients with vascular disease had significantly higher plasma SAH concentrations and significantly lower plasma SAM-to-SAH ratios and genomic DNA methylation (38). Glycine N-methyltransferase (GNMT) is the enzyme that converts SAM to SAH. We found a dramatic increase in GNMT in aortas of db/db versus control mice (supplementary Table 2) and speculated that the elevated levels of this enzyme increased SAH levels and caused DNA hypomethylation and greater Nnat expression. We found that treatment of HAECs with DNA methyl transferase inhibitor ADC increased Nnat transcript expression. ADC also induced Nnat expression in HepG2 cells (39). It is interesting to note that the leptin gene, which was also dramatically increased in aortas, is regulated by promoter methylation (40) and could also have been induced by hypomethylation.
###end p 52
###begin p 53
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
To investigate the function of Nnat in endothelial cells, Nnat was expressed in HAECs using adenovirus mediated gene transfer. Nnat expression induced a gene expression pattern characteristic of endothelial cell activation with increased inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6), endothelial cell adhesion molecules (ICAM-1, VCAM-1, and SELE), and chemokine (MCP-1) expression. Nnat expression also induced VCAM-1 expression in the mouse carotid artery. ICAM-1 expression was variable and did not show a statistically significant increase (data not shown). It is possible that the increased Nnat in the arteries of the diabetic mice increased inflammatory responses under certain conditions.
###end p 53
###begin p 54
###xml 375 377 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 378 380 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
Cell adhesion molecule and inflammatory cytokine gene expression is regulated by NF-kappaB. Expression of Nnat in HAECs increased expression of NAK, decreased IkappaB-alpha protein, and increased phosphorylation of the p65 subunit, consistent with the activation of the NF-kappaB transcription complex. TNF-alpha treatment of endothelial cells activates JNK1/2 and p38 MAPK (41-43). In our study, TNF-alpha increased JNK1/2 and p38 and inhibited Nnat-induced ERK1/2 phosphorylation. To understand whether Nnat overexpression directly induced degradation of IkappaB-alpha or increased TNF-alpha triggered activation of other NF-kappaB-regulated genes, HAECs were transduced with Ad-Nnat and incubated in medium containing TNF-alpha antibody. TNF-alpha antibody did not block Nnat-induced activation of gene expression. Therefore, Nnat effects do not appear to involve extracellular TNF-alpha interaction with cell surface receptors.
###end p 54
###begin p 55
###xml 556 558 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
We attempted to define the pathway whereby Nnat induced inflammatory gene expression. We showed that Nnat expression in HAECs induced phosphorylation of p38, JNK, ERK, and Akt. Increased Akt suggested involvement of PI 3-kinase in signal transduction from Nnat to NF-kappaB. PI 3-kinase inhibitors blocked Nnat-induced activation of IL-6 and SELE gene and VCAM-1 protein expression. SB202190, an inhibitor of p38 kinase, also blocked Nnat-induced expression of IL-6 and SELE genes. Shedding of VCAM-1 protein from cell membrane is regulated by p38 kinase (24); therefore, the seemingly paradoxical increase in VCAM-1 protein by SB202190 might be secondary to blocked shedding of this protein from the cell surface. As expected, VCAM-1 expression was blocked by an IKK inhibitor. Inhibition of JNK had no effect on SELE but decreased IL-6 mRNA and VCAM-1 protein expression.
###end p 55
###begin p 56
NF-kappaB signaling can be inhibited at several levels, including phosphorylation of Ikappa B-alpha and p65. Nnat-induced decrease in IkappaB-alpha protein level was reversed by IKK, p38, and PI 3-kinase inhibitors. Blocking IKK or p38 had no effect on phosphorylation of p65 subunit, whereas JNK1/2 and PI 3-kinase inhibitors decreased P-p65. Even though Nnat increased JNK phosphorylation, the role of this kinase in signal transduction from Nnat to NF-kappaB is not clear. Partial inhibition of gene expression by SP600125 could have resulted from decrease in p65 phosphorylation. It is also possible that JNK activates other transcription factors that work in concert with NF-kappaB.
###end p 56
###begin p 57
###xml 291 293 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 325 327 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 372 374 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
In contrast, inhibition of ERK kinase augmented Nnat-induced activation of NF-kappaB-regulated gene (IL-6 and SELE) and protein (VCAM-1) expression. Several investigators found inhibitory effects of ERK on NF-kappaB transcription factor-regulated gene expression; ERK inhibits IKK activity (44), p65 subunit phosphorylation (45), and TATA binding protein phosphorylation (46).
###end p 57
###begin p 58
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 447 451 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 728 732 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nnat</italic>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 277 282 <span type="species:ncbi:10090">mouse</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
In summary, using a gene discovery approach, we identified Nnat as a gene upregulated in the aortas of two mouse models of obesity and type 2 diabetes, db/db and high-fat-fed mice. The Nnat protein was localized to the aortic endothelium. Overexpression of Nnat in HAECs or in mouse carotid artery increased endothelial cell adhesion molecule expression. This effect of Nnat was mediated through PI 3-kinase/p38-dependent activation of NF-kappaB. Nnat is an imprinted gene, and its expression in diabetes might reflect alterations in the methylation status of endothelial cells. We conclude that Nnat is a candidate molecule involved in inflammatory pathways associated with obesity and insulin resistance. Experiments to alter Nnat gene expression in genetically modified mice are underway to assess whether Nnat expression will promote endothelial dysfunction and/or accelerate the development of atherosclerosis.
###end p 58
###begin title 59
Supplementary Material
###end title 59
###begin title 60
Online-Only Appendix
###end title 60
###begin p 61
This work has received National Institutes of Health Grant HL073191 and funding from the Arlene and Arnold Goldstein Foundation.
###end p 61
###begin p 62
Parts of this study were presented at the Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference, Chicago, Illinois, 19-21 April 2007.
###end p 62
###begin title 63
REFERENCES
###end title 63
###begin p 64
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 122 127 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 201 203 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 236 237 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 300 301 293 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 350 355 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 363 365 356 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 369 372 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 414 420 407 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 492 493 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 591 592 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 598 599 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 604 605 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 642 643 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 661 662 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 710 715 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 727 729 716 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 746 747 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 755 756 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 887 888 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 898 899 880 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
###xml 732 737 <span type="species:ncbi:10090">mouse</span>
Nnat expression in mouse aorta. A: Real-time PCR measurement of alpha-Nnat mRNA in the aortas of diabetic mice (C57BLKS/J db/db and high-fat diet-fed C57BL/6J) and their respective controls (C57BLKS/J db/+, and chow diet-fed C57BL/6J) (n = 4-6). Nnat expression levels were normalized to beta-actin. B: Representative immunohistochemical staining of db/db versus db/+ (top) and high-fat diet-versus chow diet-fed (bottom) mouse aorta paraffin sections with Nnat antibody. Magnification x100. C: Comparison of integrated intensities of Nnat staining determined using Image-Pro Plus software, n = 4. D and E: Real-time PCR data for alpha-Nnat (D) and total Nnat (E) expression in endothelial cells isolated form db/db or control db/+ mouse aortas, n = 5-6. F: Gel electrophoresis of PCR fragments amplified from endothelial cells RNA using primers for both alpha and beta Nnat isoforms. **P < 0.01, *P < 0.05. (Please see  for a high-quality digital representation of this image.)
###end p 64
###begin p 65
###xml 116 117 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 299 300 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 435 436 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 443 444 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 634 635 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 719 720 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 784 785 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 797 798 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 808 809 785 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Nnat expression in HAECs activates NF-kappaB-dependent gene expression in time- and concentration-dependent manner. A: Western blots of Nnat, VCAM-1, ICAM-1, and IkappaB-alpha protein from endothelial cells infected with Ad-Empty, Ad-GFP, and increasing number of Ad-Nnat adenovirus per cell (MOI). B: Real-time PCR measurement of IL-6 mRNA expression in endothelial cells infected with Ad-Empty, Ad-GFP, or Ad-Nnat at different MOI. (n = 3). C: Endothelial cells were collected at various times after infection with Ad-Nnat and Western blots were probed with antibodies to Nnat, NAK, IkappaB-alpha, phospho-p65, p65, and beta-actin. D: Time course of IL-6 mRNA expression after Ad-Nnat infection of endothelial cells (n = 3). IL-6 mRNA expression levels were normalized to GAPDH. ***P < 0.001, **P < 0.01, *P < 0.05. Data are a representative of three to four experiments.
###end p 65
###begin p 66
###xml 57 58 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 181 184 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 230 236 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 305 306 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 313 314 282 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 397 398 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 535 536 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 813 814 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 985 986 926 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1072 1073 1010 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1085 1086 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1096 1097 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
TNF-alpha augments Nnat-induced activation of NF-kappaB. A: Western blot for IkappaB-alpha protein in HAECs infected with Ad-Nnat in the presence or absence of exogenous TNF-alpha (top). Quantitative densitometry of Western blot (bottom) for IkappaB-alpha protein expression was normalized to beta-actin (n = 3). B: IkappaB-alpha and endothelial cell adhesion molecules VCAM-1 and ICAM-1 protein. C: ICAM-1 mRNA levels in endothelial cells infected with Ad-GFP or Ad-Nnat in the presence or absence of TNF-alpha neutralizing antibody. D: Effect of TNF-alpha blocking antibody on Nnat induced increase in cytokine IL-6 mRNA expression. Endothelial cells were infected with Ad-GFP or Ad-Nnat and treated with TNF-alpha or TNF-alpha neutralizing antibody. IL-6 and ICAM-1 expression levels were normalized to GAPDH. E: Western blot analysis of p38, SAPK/JNK1/2, and ERK1/2 MAPK phosphorylation in HAECs infected with Ad-Nnat or Ad-Empty in the presence or absence of exogenous TNF-alpha. F: Western blot analysis of Akt phosphorylation: P-AKT (S473), AKT, and beta-actin. ***P < 0.001; **P < 0.01; *P < 0.05. Data are a representative of three to four experiments.
###end p 66
###begin p 67
###xml 66 67 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 246 247 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 259 260 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 525 526 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 538 539 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 602 603 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
Effect of kinase inhibitors on Nnat-induced NF-kappaB activation. A: Western blot analysis of Ikappa B-alpha, Phospho-p65 (P-p65), VCAM-1, beta-actin P-p38, P-JNK1/2, P-ERK1/2, and P-AKT protein levels in the presence of kinase inhibitors. IL-6 (B) and SELE (C) mRNA expression in HAECs infected with Ad-Nnat. Effect of kinase inhibitors on Nnat-induced increase in IL-6 and SELE expression levels, normalized to GAPDH. I, no inhibitor; U0, U0126; SB, SB202190; SP, SP600125; LY, LY294002; W, Wortmannin; and IK, IKK-VII. ***P < 0.001, **P < 0.01. Data are representative of three to four experiments. D: Schematic describing Nnat-induced signal transduction in endothelial cells. Inhibitors of PI 3-kinase and p38 completed blocked Nnat-induced NF-kappaB activation, JNK1/2 inhibition led to a partial block, and inhibition of ERK1/2 increased NF-kappaB activation.
###end p 67
###begin p 68
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 328 329 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
Adenovirus-mediated expression of Nnat in mouse carotid arteries induced expression of VCAM-1. Immunohistochemical staining of C57BL/6J mouse carotid arteries for Nnat (A) and VCAM-1 (B) protein after incubation of blood vessels with Ad-Nnat or Ad-GFP adenovirus. C: Integrated intensity of endothelial cell staining. n = 4-7; *P < 0.05. (Please see  for a high-quality digital representation of this image.)
###end p 68
###begin p 69
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
Metabolic data for db/db and diet-induced obesity and diabetes models
###end p 69
###begin p 70
###xml 34 39 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 82 83 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 200 201 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
Data are means +/- SE. Blood from db/db mice was collected at 14-19 weeks of age (n = 18). C57BL6/J mice with diet-induced obesity and diabetes were studied after 6-20 weeks on mice on high-fat diet (n = 9). Triglyceride (TG) and total cholesterol (TC) measurements done were done at 9 weeks.
###end p 70
###begin p 71
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db/db</italic>
###xml 50 52 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">db</italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
P < 0.0001 data comparison were between db/db vs. db/+ and high-fat vs. chow-fat mice.
###end p 71
###begin p 72
Genes changed in two models of obesity and type 2 diabetes
###end p 72
###begin p 73
###xml 135 162 135 162 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
Fold change represent values obtained after data analysis with Wilcoxon test. DIO, diet-induced obesity and diabetes. See supplemental research design and methods in the online appendix for the details of the data analysis.
###end p 73
###begin p 74
Genes differentially expressed in HAECs after transduction of HAECs with Ad-Nnat
###end p 74
###begin p 75
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Data presented are representative of three to six experiments. Fold change in gene expression is determined as difference in mRNA levels for the gene of interest in Ad-Nnat-versus Ad-Empty-transduced HAECs. P values are determined using t test. n = 4.
###end p 75

